Danaher Sees Core Sales Growth of More Than 20% in 2021
October 21 2021 - 6:51AM
Dow Jones News
By Matt Grossman
Danaher Thursday tweaked its full-year guidance to be more
optimistic, forecasting that core sales growth will likely exceed
20% in 2021, rather than coming in at about that level.
The medical and diagnostics company said it expects
base-business core sales to grow by more than 10% year over year in
2021, and that core sales growth will top 20% including the
company's Covid-19 response activity.
Three months ago, Danaher was forecasting core sales growth
would be about 20% for the year.
In the fourth quarter, core revenue growth will be in the low to
mid teens year over year, Danaher forecast.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 21, 2021 06:36 ET (10:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Danaher (NYSE:DHR)
Historical Stock Chart
From Apr 2023 to Apr 2024
